Trials in India for a Safer Cancer Therapy Spurt Hope

By  ,  Onlymyhealth editorial team
May 15, 2014

The phase 2 of clinical trials of dendritic cell therapy, which is the fourth line of guard against cancer after radiotherapy, chemotherapy and surgery have been successfully completed across 6 sites in the country. Before the therapy is made available to people with malignant solid tumours, the approval of the drug controller is needed. During the trial over 51patients who suffered from refractory cancer. These patients had a life expectancy of three months or less.

dendritic cell therapyThe researchers said that the trails were conducted on patients who had an advanced stage of the disease and that it is better for one to seek treatment early. The therapy has been approved by the US Food and Drug Administration for some forms of cancer. Currently, it is being use in China, Singapore, Korea and some other countries of the European Union.

In the therapy, the blood cells or monocytes are harvested in the laboratory into dendritic cells. They are then made potent with cytokines, interleukins and growth factors. These cells are then reintroduced into the body with the help of a vaccine-like injection. The dendritic cells work as antigen presenting cells and unlike the conventional anti-cancer therapy, these cells do not have any side-effects.


Read more Health News.

Is it Helpful Article?YES2 Votes 1134 Views 0 Comment
I have read the Privacy Policy and the Terms and Conditions. I provide my consent for my data to be processed for the purposes as described and receive communications for service related information.
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK